Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anti-Infectives
Sagent Pharmaceuticals Launches Cefepime for Injection, USP
April 11th, 2008
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced that it has launched Cefepime for injection, USP, a broad spectrum antibiotic used to treat bacterial infections. Sagent's Cefepime for injection will be available in 1g and 2g single dose vials. According to IMS data, sales of Cefepime in the United States in 2006 were approximately $167 million. Sagent will begin marketing and shipping cefepime immediately. "In the past week Sagent has launched two anti-infective products, each upon the expiration of innovator exclusivity. These launches illustrate both Sagent's capabilities and the depth of our unique worldwide partnerships in...
Source: Health Business Week (2008-04-11)
|
